Italy – Prednisolut shortage

Fast delivery of Prednisolut ensures continuity of care

Italy

Critical access to anti-inflammatory therapy under pressure

Timely availability of anti-inflammatory and immunosuppressive medication is essential for patients with acute and chronic conditions. When this access is disrupted, it can have direct consequences for the stability and health of those affected.

In Italy, an urgent situation arose when a hospital was confronted with a shortage of Prednisolut 25 mg. Thanks to the rapid intervention of Orphamed, this situation was resolved within a few days. This case demonstrates how fast intervention and reliable delivery are crucial in critical moments.

Risk of interruption of essential treatments

In an Italian hospital, Prednisolut 25 mg was used for the treatment of various indications, including severe allergic reactions, autoimmune diseases, asthma and other respiratory inflammations, as well as rheumatologic conditions.

Due to a sudden product shortage, the availability of this essential medication came under significant pressure. Without a rapid solution, an interruption of treatments was imminent. This could not only worsen patients’ symptoms, but also lead to increased pressure on healthcare providers and potential complications.

Fast and reliable delivery via Orphamed

Orphamed was engaged to resolve the shortage and acted immediately. Thanks to its international network and experience in organizing pharmaceutical supply, it was able to respond quickly to the demand.

Within a short timeframe, Orphamed delivered 333 packages of Prednisolut 25 mg to the hospital. The delivery took place within an appropriate and rapid timeframe, ensuring continuity of care.

Continuity of care ensured

Thanks to Orphamed’s fast and efficient approach, treatments could continue without interruption. Patients maintained access to the necessary therapy during a critical period of shortage.

This case underlines the importance of reliable partners in the pharmaceutical supply chain and shows how rapid access to medication has a direct impact on patient care and treatment continuity.